Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis

The human lymphocyte antigen B27 (HLA B27) is a member of the HLA class I family of genes in the major histocompatibility complex whose name goes back to its discovery in studies of transplanted tissue compatibility. Its prevalence in the mid-European population is about 8%. The association of HLA B...

Full description

Bibliographic Details
Main Authors: Joachim Sieper, Juergen Braun
Format: Article
Language:English
Published: BMJ Publishing Group 2023-07-01
Series:RMD Open
Online Access:https://rmdopen.bmj.com/content/9/3/e003102.full
_version_ 1797640259134029824
author Joachim Sieper
Juergen Braun
author_facet Joachim Sieper
Juergen Braun
author_sort Joachim Sieper
collection DOAJ
description The human lymphocyte antigen B27 (HLA B27) is a member of the HLA class I family of genes in the major histocompatibility complex whose name goes back to its discovery in studies of transplanted tissue compatibility. Its prevalence in the mid-European population is about 8%. The association of HLA B27 alleles with ankylosing spondylitis (AS), a highly heritable disease, which is part of the spectrum of axial spondyloarthritis (axSpA), was discovered 50 years ago. HLA B27 explains less than 30% of the total genetic load. About 60%–90% of axSpA patients worldwide carry HLA B27. The prevalence of the disease is linked to the frequency of HLA B27 in the population which implies that there are relevant differences. Among the roughly 200 subtypes known there are two which are not disease associated. The function of HLA class I molecules is to present peptides to the immune system to defend the organism against microbes targeted by CD8+T cells. This is much supported by the role of the endoplasmic reticulum aminopeptidase 1 (ERAP 1) in AS, an enzyme that is responsible for the intracellular trimming of peptides, since polymorphisms of this gene are only associated with HLA-B27+ disease. The arthritogenic peptide hypothesis trying to explain the pathogenesis of AS is based on that very immune function assuming that also self peptides can be presented. HLA-B27 also plays an important role in classification, diagnosis and severitiy of axSpA.
first_indexed 2024-03-11T13:29:20Z
format Article
id doaj.art-42c2d8f1d8a8462dbb79cdae0f3298a0
institution Directory Open Access Journal
issn 2056-5933
language English
last_indexed 2024-03-11T13:29:20Z
publishDate 2023-07-01
publisher BMJ Publishing Group
record_format Article
series RMD Open
spelling doaj.art-42c2d8f1d8a8462dbb79cdae0f3298a02023-11-03T03:15:08ZengBMJ Publishing GroupRMD Open2056-59332023-07-019310.1136/rmdopen-2023-003102Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitisJoachim Sieper0Juergen Braun1Department of Rheumatology, Charite Universitatsmedizin Berlin, Berlin, GermanyRheumazentrum Ruhrgebiet, Ruhr University Bochum, Herne, GermanyThe human lymphocyte antigen B27 (HLA B27) is a member of the HLA class I family of genes in the major histocompatibility complex whose name goes back to its discovery in studies of transplanted tissue compatibility. Its prevalence in the mid-European population is about 8%. The association of HLA B27 alleles with ankylosing spondylitis (AS), a highly heritable disease, which is part of the spectrum of axial spondyloarthritis (axSpA), was discovered 50 years ago. HLA B27 explains less than 30% of the total genetic load. About 60%–90% of axSpA patients worldwide carry HLA B27. The prevalence of the disease is linked to the frequency of HLA B27 in the population which implies that there are relevant differences. Among the roughly 200 subtypes known there are two which are not disease associated. The function of HLA class I molecules is to present peptides to the immune system to defend the organism against microbes targeted by CD8+T cells. This is much supported by the role of the endoplasmic reticulum aminopeptidase 1 (ERAP 1) in AS, an enzyme that is responsible for the intracellular trimming of peptides, since polymorphisms of this gene are only associated with HLA-B27+ disease. The arthritogenic peptide hypothesis trying to explain the pathogenesis of AS is based on that very immune function assuming that also self peptides can be presented. HLA-B27 also plays an important role in classification, diagnosis and severitiy of axSpA.https://rmdopen.bmj.com/content/9/3/e003102.full
spellingShingle Joachim Sieper
Juergen Braun
Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
RMD Open
title Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
title_full Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
title_fullStr Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
title_full_unstemmed Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
title_short Fifty years after the discovery of the association of HLA B27 with ankylosing spondylitis
title_sort fifty years after the discovery of the association of hla b27 with ankylosing spondylitis
url https://rmdopen.bmj.com/content/9/3/e003102.full
work_keys_str_mv AT joachimsieper fiftyyearsafterthediscoveryoftheassociationofhlab27withankylosingspondylitis
AT juergenbraun fiftyyearsafterthediscoveryoftheassociationofhlab27withankylosingspondylitis